PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):1–10. doi: 10.3322/caac.21492.
   Web of Science ®Google Scholar
• Harada K, Rogers JE, Iwatsuki M, et al. Recent advances in treating oesophageal cancer. F1000Res. 2020;9:1189. doi: 10.12688/f1000research.22926.1.
   Google Scholar
• Niu C, Liu Y, Wang J, et al. Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study. BMC Cancer. 2021;21(1):1034. doi: 10.1186/s12885-021-08764-x.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang B, Ma Y, et al. Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma. Signal Transduct Target Ther. 2021;6(1):381. doi: 10.1038/s41392-021-00682-5.
   PubMed Web of Science ®Google Scholar
• Ko KP, Huang Y, Zhang S, et al. Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion. Gastroenterology. 2023;165(3):613–628.e20. doi: 10.1053/j.gastro.2023.05.030.
   PubMed Web of Science ®Google Scholar
• Chen T, Cheng H, Chen X, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep. 2015;5(1):16038. doi: 10.1038/srep16038.
   PubMedGoogle Scholar
• Dong J, Buas MF, Gharahkhani P, et al. Determining risk of Barrett’s esophagus and esophageal adenocarcinoma based on epidemiologic factors and genetic variants. Gastroenterology. 2018;154(5):1273–1281.e3. doi: 10.1053/j.gastro.2017.12.003.
   PubMed Web of Science ®Google Scholar
• Jajosky A, Fels Elliott DR. Esophageal cancer genetics and clinical translation. Thorac Surg Clin. 2022;32(4):425–435. doi: 10.1016/j.thorsurg.2022.06.002.
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Shukla SD, Dua K, et al. The role of epidermal growth factor receptor in the management of gastrointestinal carcinomas: present status and future perspectives. Curr Pharm Des. 2017;23(16):2314–2320. doi: 10.2174/1381612823666170124115159.
   PubMed Web of Science ®Google Scholar
• Shen Y, Shao Y, Ruan X, et al. Genetic variant in miR-17-92 cluster binding sites is associated with esophageal squamous cell carcinoma risk in Chinese population. BMC Cancer. 2022;22(1):1253. doi: 10.1186/s12885-022-10360-6.
   PubMed Web of Science ®Google Scholar
• Xu X, Sun Z, Rong L, et al. Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy. Front Genet. 2022;13:988433. doi: 10.3389/fgene.2022.988433.
   PubMed Web of Science ®Google Scholar
• van den Maagdenberg AM, Olde Weghuis D, Rijss J, et al. The gene (PTPN13) encoding the protein tyrosine phosphatase PTP-BL/PTP-BAS is located in mouse chromosome region 5E/F and human chromosome region 4q21. Cytogenet Cell Genet. 1996;74(1–2):153–155. doi: 10.1159/000134405.
   PubMedGoogle Scholar
• McHeik S, Aptecar L, Coopman P. et al. Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer. Biomolecules. 2020;10(12):1659.
   Google Scholar
• Freiss G, Chalbos D. PTPN13/PTPL1: an important regulator of tumor aggressiveness. Anticancer Agents Med Chem. 2011;11(1):78–88. doi: 10.2174/187152011794941262.
   PubMed Web of Science ®Google Scholar
• Yu M, Maden SK, Stachler M, et al. Subtypes of barrett’s oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut. 2019;68(3):389–399. doi: 10.1136/gutjnl-2017-314544.
   PubMed Web of Science ®Google Scholar
• Laczmanska I, Karpinski P, Gil J, et al. The PTPN13 Y2081D (T > G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer. Colorectal Dis. 2017;19(7):O272–O278. O272-o8. doi: 10.1111/codi.13727.
   PubMed Web of Science ®Google Scholar
• Wei W, Jiang M, Luo L, et al. Colorectal cancer susceptibility variants alter risk of breast cancer in a chinese han population. Genet Mol Res. 2013;12(4):6268–6274. doi: 10.4238/2013.December.4.14.
   PubMed Web of Science ®Google Scholar
• Niu J, Huang YJ, Wang LE, et al. Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. Carcinogenesis. 2009;30(12):2053–2058. doi: 10.1093/carcin/bgp265.
   PubMed Web of Science ®Google Scholar
• Shieh SY, Ahn J, Tamai K, et al. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000;14(3):289–300. doi: 10.1101/gad.14.3.289.
   PubMed Web of Science ®Google Scholar
• Nguyen-Dumont T, Dowty JG, Steen JA, et al. Population-based estimates of the age-specific cumulative risk of breast cancer for pathogenic variants in CHEK2: findings from the Australian breast cancer family registry. Cancers . 2021;13(6):1378. doi: 10.3390/cancers13061378.
   PubMed Web of Science ®Google Scholar
• Fei-Fei H, Chang-Long G, Li-Hong L. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol. 2013;32(6):329–335. doi: 10.1089/dna.2013.1970.
   PubMed Web of Science ®Google Scholar
• Hu N, Kadota M, Liu H, et al. Genomic landscape of somatic alterations in esophageal squamous cell carcinoma and gastric cancer. Cancer Res. 2016;76(7):1714–1723. doi: 10.1158/0008-5472.CAN-15-0338.
   PubMed Web of Science ®Google Scholar
• Jia X, Liu P, Zhang M, et al. Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population. Int J Clin Exp Med. 2015;8(10):19381–19387.
   PubMed Web of Science ®Google Scholar
• Yang J, Wu H, Wei S, et al. HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of esophageal squamous cell carcinoma (ESCC). BMC Cancer. 2014;14(1):501. doi: 10.1186/1471-2407-14-501.
   PubMedGoogle Scholar
• Gabriel S, Ziaugra L. SNP genotyping using sequenom MassARRAY 7K platform. Curr Protoc Hum Genet. 2004; Chapter 2:Unit 2.12. doi: 10.1002/0471142905.hg0212s42.
   PubMedGoogle Scholar
• Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000;320(7247):1468–1468. doi: 10.1136/bmj.320.7247.1468.
   PubMed Web of Science ®Google Scholar
• Wacholder S, Chanock S, Garcia-Closas M, et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434–442. doi: 10.1093/jnci/djh075.
   PubMed Web of Science ®Google Scholar
• Mita Y, Yasuda Y, Sakai A, et al. Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers. J Cancer Res Clin Oncol. 2010;136(2):249–259. doi: 10.1007/s00432-009-0656-7.
   PubMed Web of Science ®Google Scholar
• Jalilvand M, Oloomi M, Najafipour R, et al. An association study between CHEK2 gene mutations and susceptibility to breast cancer. Comp Clin Path. 2017;26(4):837–845. doi: 10.1007/s00580-017-2455-x.
   PubMedGoogle Scholar
• Kate L, Iversen ES, Jonathan T, et al. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis. 2015;36(11):1341–1353. doi: 10.1093/carcin/bgv138.
   PubMed Web of Science ®Google Scholar
• Wang Y, Dai B, Ye D. CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(9):15708–15715.
   PubMed Web of Science ®Google Scholar
• Monika SE, Cezary C, Danuta GSP, et al. CHEK2 mutations and the risk of papillary thyroid cancer. Int J Cancer. 2015;137(3):548–552.
   PubMed Web of Science ®Google Scholar
• Xu W, Liu D, Yang Y, et al. Association of CHEK2 polymorphisms with the efficacy of platinum-based chemotherapy for advanced non-small-cell lung cancer in Chinese never-smoking women. J Thorac Dis. 2016;8(9):2519–2529. doi: 10.21037/jtd.2016.08.70.
   PubMed Web of Science ®Google Scholar
• Gu H, Qiu W, Wan Y, et al. Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population. Mol Biol Rep. 2012;39(5):5977–5984. doi: 10.1007/s11033-011-1410-1.
   PubMed Web of Science ®Google Scholar
• Jia X, Liu P, Zhang M, et al. Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in the Chinese Han population. Int J Clin Exp Med. 2015;8(10):19381.
   PubMed Web of Science ®Google Scholar
• Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360–373. doi: 10.1053/j.gastro.2017.08.023.
   PubMed Web of Science ®Google Scholar
• Chung CS, Lee YC, Wang CP, et al. Secondary prevention of esophageal squamous cell carcinoma in areas where smoking, alcohol, and betel quid chewing are prevalent. J Formos Med Assoc. 2010;109(6):408–421. doi: 10.1016/S0929-6646(10)60072-1.
   PubMed Web of Science ®Google Scholar
• Ferndale L, Aldous C, Hift R, et al. Gender differences in oesophageal squamous cell carcinoma in a South African tertiary hospital. Int J Environ Res Public Health. 2020;17(19):7086. doi: 10.3390/ijerph17197086.
   PubMed Web of Science ®Google Scholar